Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
0.1% RGN-259 (Thymosin 4) ophthalmic solution promotes healing and improves comfort in neurotrophic keratopathy patients in a randomized, placebo-controlled, double-masked Phase III clinical trial
,
It generally equates to 240 units, but always confirm with your clinics guidance
Peptide purity, accurate labelling and reliable logistics directly affect whether experimental results are reproducible and imported research chemicals frequently arrive with none of those assurances, and with customs delays or seizures on top
This is the level of detail we operate on when producing our peptides at Real Peptides, and it's the level of detail that should be applied in the lab
US$ 20.21
US$ 22.52
US$ 27.73
US$ 25.47
